Archit Organosys Limited (BOM:524640)
India · Delayed Price · Currency is INR 61.82
-1.67 (-2.63%)
At close: Oct 1, 2026
Archit Organosys Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,448 | 1,410 | 1,256 | 1,132 | 1,278 | 1,367 |
Other Revenue | - | - | 0.71 | - | - | - |
| 1,448 | 1,410 | 1,257 | 1,132 | 1,278 | 1,367 | |
Revenue Growth | 9.90% | 12.16% | 11.03% | -11.42% | -6.50% | 44.60% |
Cost of Revenue | 1,055 | 995.56 | 882.51 | 788.21 | 776.99 | 959.52 |
Gross Profit | 393.14 | 413.96 | 374.2 | 343.7 | 500.84 | 407.12 |
Selling, General & Admin | 73.81 | 77.89 | 76.34 | 63.24 | 76.35 | 66.54 |
Other Operating Expenses | 162.9 | 169.6 | 166.73 | 210.06 | 222.45 | 169.36 |
Operating Expenses | 296.99 | 307.63 | 302.49 | 329.89 | 347.6 | 282.76 |
Operating Income | 96.15 | 106.33 | 71.71 | 13.81 | 153.24 | 124.36 |
Interest Expense | -21.33 | -21.75 | -24.76 | -24.59 | -20.92 | -24.45 |
Interest & Investment Income | - | 27.3 | 26.77 | 14.01 | 3.06 | 10.69 |
Currency Exchange Gain (Loss) | - | 2.24 | 2.42 | 2.42 | 2.25 | 3.93 |
Other Non Operating Income (Expenses) | 24.94 | -1.13 | 0.48 | -0.62 | -0.66 | 0.47 |
EBT Excluding Unusual Items | 99.76 | 112.99 | 76.61 | 5.03 | 136.96 | 114.99 |
Gain (Loss) on Sale of Investments | - | -2.03 | -1.35 | 3.19 | 4.45 | - |
Gain (Loss) on Sale of Assets | - | -1.4 | - | -1.15 | -6.17 | -4.83 |
Legal Settlements | - | - | - | -25.05 | - | - |
Other Unusual Items | - | - | - | 59.24 | 18.14 | - |
Pretax Income | 99.76 | 109.93 | 75.39 | 43.87 | 153.58 | 114.25 |
Income Tax Expense | 25.33 | 29.6 | 24.88 | 10.49 | 40.09 | 31.94 |
Net Income | 74.43 | 80.32 | 50.51 | 33.38 | 113.49 | 82.32 |
Net Income to Common | 74.43 | 80.32 | 50.51 | 33.38 | 113.49 | 82.32 |
Net Income Growth | 22.39% | 59.02% | 51.33% | -70.59% | 37.87% | 64.42% |
Shares Outstanding (Basic) | 20 | 21 | 21 | 21 | 21 | 21 |
Shares Outstanding (Diluted) | 20 | 21 | 21 | 21 | 21 | 21 |
Shares Change | -0.49% | - | - | - | - | 36.62% |
EPS (Basic) | 3.63 | 3.91 | 2.46 | 1.63 | 5.53 | 4.01 |
EPS (Diluted) | 3.63 | 3.91 | 2.46 | 1.63 | 5.53 | 4.01 |
EPS Growth | 22.99% | 59.02% | 51.33% | -70.59% | 37.87% | 20.46% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 14.4 | 180.23 | 85.84 | 12.19 | -2.18 |
Free Cash Flow Per Share | - | 0.70 | 8.78 | 4.18 | 0.59 | -0.11 |
Dividend Per Share | - | 1.000 | 0.500 | - | 0.500 | 0.750 |
Dividend Growth | - | 100.00% | - | - | -33.33% | 50.00% |
Gross Margin | 27.14% | 29.37% | 29.78% | 30.36% | 39.20% | 29.79% |
Operating Margin | 6.64% | 7.54% | 5.71% | 1.22% | 11.99% | 9.10% |
Profit Margin | 5.14% | 5.70% | 4.02% | 2.95% | 8.88% | 6.02% |
Free Cash Flow Margin | - | 1.02% | 14.34% | 7.58% | 0.95% | -0.16% |
EBITDA | 156.95 | 164.59 | 129.24 | 68.59 | 195.94 | 164.56 |
EBITDA Margin | 10.84% | 11.68% | 10.28% | 6.06% | 15.33% | 12.04% |
D&A For EBITDA | 60.8 | 58.26 | 57.54 | 54.78 | 42.7 | 40.2 |
EBIT | 96.15 | 106.33 | 71.71 | 13.81 | 153.24 | 124.36 |
EBIT Margin | 6.64% | 7.54% | 5.71% | 1.22% | 11.99% | 9.10% |
Effective Tax Rate | 25.39% | 26.93% | 33.00% | 23.91% | 26.10% | 27.95% |
Revenue as Reported | 1,473 | 1,438 | 1,287 | 1,157 | 1,296 | 1,386 |